KINTAI Biotech Reports on Growing Demand for Canine Joint Health Supplements

KINTAI Biotech Inc., a producer of methylsulfonylmethane (MSM) powder, has highlighted the growing demand within the canine joint health supplement market. The company emphasizes that MSM, also known as dimethyl sulfone, is a common ingredient in pet supplements due to its anti-inflammatory properties and its role in supporting connective tissues.

MSM is an organic sulfur compound naturally found in animals and humans. It has demonstrated various biological functions, including anti-inflammatory and antioxidant effects, and supports connective tissue health. These attributes make it a significant component in canine joint health products, particularly for managing common orthopedic issues such as patellar luxation.

KINTAI Biotech offers high-purity MSM powder with a minimum purity of 98%, commonly at 99.9%. The company serves global pet supplement manufacturers by providing customized particle sizes, packaging options, and comprehensive Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS). Their products are supplied in bulk, positioning KINTAI Biotech as a reliable raw material partner for companies developing canine joint health products.

The market for canine joint health solutions is experiencing continuous growth, with a strong demand for effective supplements. MSM's ability to support joint mobility and reduce inflammation makes it a key ingredient in products aimed at enhancing pet well-being. KINTAI Biotech is positioning itself as a key supplier in this expanding market segment by offering quality MSM to international clients.